Qu Biologics.png
Qu Biologics Files Important New IP for the Treatment of Post-Surgical Immune Dysfunction and Prevention of Cancer Metastasis
May 12, 2021 09:00 ET | Qu Biologics, Inc.
VANCOUVER, British Columbia, May 12, 2021 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a private clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform...
Emergen logo.png
Near-Infrared Imaging Market Size to Reach USD 1,535.0 Million in 2028 | Rise in Number of Surgeries Being Conducted Due to Increasing Prevalence of Chronic Diseases Is a Key Factor Driving Industry Growth, says Emergen Research
March 23, 2021 18:00 ET | Emergen Research
Vancouver, British Columbia, March 23, 2021 (GLOBE NEWSWIRE) -- The global near-infrared imaging market size is expected to reach USD 1,535.0 Million at a steady CAGR of 13.2% in 2028, according to...